Multiple Sclerosis: New Insights in Pathogenesis and Novel Therapeutics
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multiple Sclerosis: New Insights in Pathogenesis and Novel Therapeutics
Authors
Keywords
-
Journal
Annual Review of Medicine
Volume 63, Issue 1, Pages 389-404
Publisher
Annual Reviews
Online
2011-03-03
DOI
10.1146/annurev-med-042910-135833
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
- (2011) Ralf A. Linker et al. BRAIN
- Relationship of UV exposure to prevalence of multiple sclerosis in England
- (2011) S. V. Ramagopalan et al. NEUROLOGY
- Sun exposure and vitamin D are independent risk factors for CNS demyelination
- (2011) R. M. Lucas et al. NEUROLOGY
- Evidence for Polygenic Susceptibility to Multiple Sclerosis—The Shape of Things to Come
- (2010) AMERICAN JOURNAL OF HUMAN GENETICS
- Reply
- (2010) Florian Doepp et al. ANNALS OF NEUROLOGY
- Anti-JC virus antibodies: Implications for PML Risk Stratification
- (2010) Leonid Gorelik et al. ANNALS OF NEUROLOGY
- A phase 3 trial of extended release oral dalfampridine in multiple sclerosis
- (2010) Andrew D. Goodman et al. ANNALS OF NEUROLOGY
- Safety and Immunological Effects of Mesenchymal Stem Cell Transplantation in Patients With Multiple Sclerosis and Amyotrophic Lateral Sclerosis
- (2010) Dimitrios Karussis et al. ARCHIVES OF NEUROLOGY
- Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis
- (2010) Chris H Polman et al. LANCET NEUROLOGY
- Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
- (2010) Daniel Wynn et al. LANCET NEUROLOGY
- Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
- (2010) Raju Kapoor et al. LANCET NEUROLOGY
- Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis
- (2010) Sergio E. Baranzini et al. NATURE
- T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
- (2010) Robert C Axtell et al. NATURE MEDICINE
- A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
- (2010) J. M. Burton et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Major Histocompatibility Class I Locus Contributes to Multiple Sclerosis Susceptibility Independently from HLA-DRB1*15:01
- (2010) Bruce A. C. Cree et al. PLoS One
- T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-β
- (2009) Luca Durelli et al. ANNALS OF NEUROLOGY
- FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
- (2009) Volker Brinkmann BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacokinetic, pharmacodynamic, and safety profiles of PEGylated interferon beta-1a in healthy volunteers: Results from two Phase 1 clinical studies
- (2009) Gudarz Davar et al. CYTOKINE
- One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis
- (2009) L. Prosperini et al. EUROPEAN JOURNAL OF NEUROLOGY
- Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis
- (2009) Jean E. Merrill et al. JOURNAL OF NEUROLOGY
- The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis
- (2009) Paolo Zamboni et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency
- (2009) Paolo Zamboni et al. JOURNAL OF VASCULAR SURGERY
- Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial
- (2009) Andrew D Goodman et al. LANCET
- Measures in the first year of therapy predict the response to interferon β in MS
- (2009) J Río et al. Multiple Sclerosis Journal
- Remyelination capacity of the MS brain decreases with disease chronicity
- (2009) T. Goldschmidt et al. NEUROLOGY
- Gray matter atrophy in multiple sclerosis: A longitudinal study
- (2008) Elizabeth Fisher et al. ANNALS OF NEUROLOGY
- Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
- (2008) Bruce D. Trapp et al. Annual Review of Neuroscience
- Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
- (2008) G Comi et al. LANCET
- Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
- (2008) Ludwig Kappos et al. LANCET
- Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started